Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.
about
Advances in enteric disease vaccines: from innovation to implementationDesigning vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli.Novel antigens for enterotoxigenic Escherichia coli vaccinesSafety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.Immunization with a Double-Mutant (R192G/L211A) of the Heat-Labile Enterotoxin of Escherichia coli Offers Partial Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model.Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates.U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in MiceImplications of enterotoxigenic Escherichia coli genomics for vaccine development.Preformulation studies with the Escherichia coli double mutant heat-labile toxin adjuvant for use in an oral vaccine.A Novel Method for Efficient Preparation of Mucosal Adjuvant Escherichia coli Heat-Labile Enterotoxin Mutant (LTm) by Artificially Assisted Self-Assembly In Vitro.Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLTRotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model
P2860
Q30359498-FA69D115-E6E4-4A53-B7DC-79AB89296A1AQ33813634-7C6E4312-9E81-4788-A33C-EC721527AFBEQ34349166-FEB90884-AE9D-4551-8470-BAA2CBF4F8E5Q34784973-8163CC6F-B2B8-493F-A687-90B20844C46DQ35833473-3BACDD13-4F6D-4304-BB50-2C14CE14B67EQ35886523-810C9459-34CB-40B8-A68F-DBE5BA366EEEQ35887055-1CA9118C-D354-4343-8B62-46DB56ECDDACQ37350955-BCFC4F7D-07A7-4C4F-94AD-CA95108EE9ADQ37647549-36A981DD-4108-478B-A106-05B14EBCCB0DQ38300751-ABA94E0F-9D1B-46F2-9E6E-F3CCC74DC4E7Q47093864-080EB86E-9D98-48DE-B28A-3A3CDD1BD720Q51521036-488D5AC6-4501-4CE7-920A-20AB13547484Q55042601-4E6142B2-F907-483C-AE40-FD50DFEF680BQ57945015-548382BC-A7B6-42E6-B9A6-18CD00322B2BQ58759991-ECD4701E-EAC7-44C5-BC45-28EDBF5EB8A0
P2860
Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and immunogenicity of a ...... erotoxigenic Escherichia coli.
@en
Safety and immunogenicity of a ...... erotoxigenic Escherichia coli.
@nl
type
label
Safety and immunogenicity of a ...... erotoxigenic Escherichia coli.
@en
Safety and immunogenicity of a ...... erotoxigenic Escherichia coli.
@nl
prefLabel
Safety and immunogenicity of a ...... erotoxigenic Escherichia coli.
@en
Safety and immunogenicity of a ...... erotoxigenic Escherichia coli.
@nl
P2093
P2860
P356
P1476
Safety and immunogenicity of a ...... erotoxigenic Escherichia coli.
@en
P2093
A Louis Bourgeois
Lillian Van De Verg
Mardi Reymann
Nicole Bauers
Samer S El-Kamary
Wilbur H Chen
P2860
P304
P356
10.1128/CVI.00464-13
P577
2013-09-18T00:00:00Z